scholarly journals Influence of SPRINT Study Type Automated Office Blood Pressure Measurements on Hypertension Diagnosis in Kidney Transplant Patients

2018 ◽  
Vol 43 (2) ◽  
pp. 310-317 ◽  
Author(s):  
Akanksha Bhatnagar ◽  
Ulrich Pein ◽  
Silke Markau ◽  
Karl Weigand ◽  
Paolo Fornara ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Kidney Transplant ◽  
Office Blood Pressure ◽  
Pressure Measurements ◽  
Transplant Patients ◽  
Kidney Transplant Patients ◽  
Hypertension Diagnosis ◽  
Automated Office Blood Pressure ◽  
Study Type

The Gap Between Manual and Automated Office Blood Pressure Measurements Results at a Hypertension Clinic

2017 ◽  
Vol 33 (5) ◽  
pp. 653-657 ◽  
Author(s):  
Félix Rinfret ◽  
Lyne Cloutier ◽  
Hélène L'Archevêque ◽  
Martine Gauthier ◽  
Mikhael Laskine ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Office Blood Pressure ◽  
Pressure Measurements ◽  
Hypertension Clinic ◽  
Automated Office Blood Pressure

Circadian Rhythm of Blood Pressure and Heart Rate in Healthy Persons and Kidney Transplant Patients: Correlations with Activity

1995 ◽  
Vol 12 (6) ◽  
pp. 419-426 ◽  
Author(s):  
Verghese Thomas ◽  
Wenyaw Chan ◽  
Robert Yetman ◽  
Michael H. Smolensky ◽  
Barry D. Kahan ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Heart Rate ◽  
Circadian Rhythm ◽  
Kidney Transplant ◽  
Transplant Patients ◽  
Kidney Transplant Patients ◽  
Healthy Persons

scholarly journals Efficacy and Safety of SGLT-2 Inhibitors for Treatment of Diabetes Mellitus among Kidney Transplant Patients: A Systematic Review and Meta-Analysis

2020 ◽  
Vol 8 (4) ◽  
pp. 47
Author(s):  
Api Chewcharat ◽  
Narut Prasitlumkum ◽  
Charat Thongprayoon ◽  
Tarun Bathini ◽  
Juan Medaura ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Systematic Review ◽  
Blood Pressure ◽  
Body Weight ◽  
Kidney Transplant ◽  
Meta Analysis ◽  
Efficacy And Safety ◽  
Transplant Patients ◽  
Treatment Of Diabetes ◽  
Kidney Transplant Patients

Background: The objective of this systematic review was to evaluate the efficacy and safety profiles of sodium-glucose co-transporter 2 (SGLT-2) inhibitors for treatment of diabetes mellitus (DM) among kidney transplant patients. Methods: We conducted electronic searches in Medline, Embase, Scopus, and Cochrane databases from inception through April 2020 to identify studies that investigated the efficacy and safety of SGLT-2 inhibitors in kidney transplant patients with DM. Study results were pooled and analyzed utilizing random-effects model. Results: Eight studies with 132 patients (baseline estimated glomerular filtration rate (eGFR) of 64.5 ± 19.9 mL/min/1.73 m2) treated with SGLT-2 inhibitors were included in our meta-analysis. SGLT-2 inhibitors demonstrated significantly lower hemoglobin A1c (HbA1c) (WMD = −0.56% [95%CI: −0.97, −0.16]; p = 0.007) and body weight (WMD = −2.16 kg [95%CI: −3.08, −1.24]; p < 0.001) at end of study compared to baseline level. There were no significant changes in eGFR, serum creatinine, urine protein creatinine ratio, and blood pressure. By subgroup analysis, empagliflozin demonstrated a significant reduction in body mass index (BMI) and body weight. Canagliflozin revealed a significant decrease in HbA1C and systolic blood pressure. In terms of safety profiles, fourteen patients had urinary tract infection. Only one had genital mycosis, one had acute kidney injury, and one had cellulitis. There were no reported cases of euglycemic ketoacidosis or acute rejection during the treatment. Conclusion: Among kidney transplant patients with excellent kidney function, SGLT-2 inhibitors for treatment of DM are effective in lowering HbA1C, reducing body weight, and preserving kidney function without reporting of serious adverse events, including euglycemic ketoacidosis and acute rejection.

scholarly journals Attended and Unattended Automated Office Blood Pressure Measurements Have Better Agreement With Ambulatory Monitoring Than Conventional Office Readings

2018 ◽  
Vol 7 (8) ◽  
Author(s):  
Emmanuel A. Andreadis ◽  
Charalampia V. Geladari ◽  
Epameinondas T. Angelopoulos ◽  
Florentia S. Savva ◽  
Anna I. Georgantoni ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Ambulatory Monitoring ◽  
Office Blood Pressure ◽  
Pressure Measurements ◽  
Automated Office Blood Pressure
Sign in / Sign up

Export Citation Format

Share Document